Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

Collecting local data, safety and experience trial.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Disorder Cardiovascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients; Post Acute Coronary Syndrome

Exclusion criteria

Treatment and study plan

ezetimibe

Drug

Ezetimibe 10 mg daily for 42 days.

Other names: Ezetrol®, Zetia®, MK0653

simvastatin

Drug

simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days.

Other names: Zocor®, MK0733

Primary outcomes

LDL levels

Time frame: 42 Days

Secondary outcomes

Safety measures

Time frame: 42 days
Total cholesterol levels.

Time frame: 42 Days

Sponsors and collaborators

Lead sponsor

Organon and Co

Industry

Registry information

Official study title

A Multicenter, Open Study To Evaluate The Efficacy Of Ezetimibe 10 Mg Added On Statin Therapy, In Reducing LDL Cholesterol To Target Levels In Patients After Acute Coronary Syndrome

Important dates

Study start: 2005
Primary completion: 2005
Study completion: 2005
First posted: Apr 4, 2008
Registry last updated: Aug 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed